The phrase "assurance needs" is correct and usable in written English.
It can be used in contexts related to requirements or expectations for assurance, such as in business, finance, or personal development.
Example: "In order to proceed with the project, we must first identify the assurance needs of all stakeholders involved."
Alternatives: "requirements for assurance" or "assurance requirements".
"Freelancers should also consider reviewing their life assurance needs.
Such assurance needs to be negotiated with the Pakistani army and intelligence; success in that could bear more fruit than any national reconciliation or reintegration plan inside Afghanistan.
The evaluation of subsea flow assurance needs to be performed considering the performance of a subsea production plant, reservoir production characteristics, and the flow characteristics of multiphase fluids.
This experience has taught the geothermal community that flow assurance needs to be addressed ahead of time to prevent issues triggered by the chemical interaction between the injected fluid and the receiving rock, which can impair the overall success of an EGS project.
I have argued that BUPLAS (VA) for work reflects a 'weak' version of assessment tailored to recruitment needs, whilst BUPLAS (CA) at work reflects a 'strong' version of assessment tailored to the business quality assurance needs, a key one being coaching feedback.
For instance, at Johnson & Johnson's pharmaceutical R&D group, Thomas Kirsch, the head of global quality assurance, needed to integrate the QA functions for two traditionally autonomous clinical R&D units whose people were located around the world.
Once specifics of the testing are determined (i.e. sample number, species, scheduling, reagents, quality assurance needed, etc). and a price has been quoted for the work, please refer to the Sample Submission instructions and the Billing Procedures.
Homejoy was structured as a contractor-for-hire business, with limited training and quality assurance needed for its pros.
TDDSs are intended for topical application, hence, the prime assurance needed for such formulations is their biocompatibility with the skin (site of action), i.e., their use must not lead to any kind of inflammatory reactions.
The incorporation of surrogate and tumour pharmacodynamic markers into clinical trials has also highlighted the fact that assay validation, reliability and quality assurance need attention if results are to be interpretable (Colburn, 2003; Cummings et al, 2004).
The hope is that this will give energy firms the assurances needed to invest in new forms of generation.
